ZZM-1220
ZZM-1220 is a covalent G9a/GLP histone methyltransferase inhibitor with IC50 values of 458 nM and 924 nM, respectively. It reduces cellular H3K9me2 levels, induces apoptosis, and causes G2/M phase arrest in triple-negative breast cancer cells, making it a useful probe for epigenetic and oncology research.
Product Specifications
Field of Research
Cell Biology, Epigenetics & Chromatin
Molecular Formula
C25H29N5O3
Molecular Weight
447.53
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog